Epigenomics AG  

(Public, ETR:ECX)   Watch this stock  
Find more results for ECX
3.45
+0.01 (0.26%)
Oct 20 - Close
ETR data delayed by 15 mins - Disclaimer
Currency in EUR
Range 3.25 - 3.47
52 week 2.80 - 8.86
Open 3.35
Vol / Avg. 23,464.00/22,379.00
Mkt cap 44.81M
P/E     -
Div/yield     -
EPS -0.63
Shares 13.51M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -450.12% -466.69%
Operating margin -399.01% -458.94%
EBITD margin - -406.68%
Return on average assets -68.35% -82.53%
Return on average equity -125.27% -139.61%
Employees 38 -
CDP Score - -

Address

Kleine Praesidentenstrasse 1
BERLIN, 10178
Germany
+49-30-243450 (Phone)
+49-30-24345555 (Fax)

Website links

Description

Epigenomics AG is a Germany-based company engaged in the molecular diagnostics sector. The Company focuses on the developing and commercializing of in vitro diagnostic (IVD) tests for the screening and diagnosis of cancer. Epigenomics AG develops and markets cancer diagnostic tests in colorectal cancer (CRC) and in lung cancer. The Company�s main product is Epi proColon, a blood-based test for the early detection of CRC, which relies on its proprietary deoxyribonucleic acid (DNA) methylation biomarker, Septin9. Epi proColon is marketed in Europe and is in development for the United States. It develops its solutions together with its commercial partners, Abbott Molecular Inc and Quest Diagnostics Inc. Epigenomics AG, as the parent company, oversees the Group�s central business functions, including accounting, human resources and intellectual property, among others.

Officers and directors

Heino Von Prondzynski Chairman of the Supervisory Board
Age: 64
Thomas Taapken Member of the Executive Board, Chief Executive Officer, Chief Financial Officer
Age: 48
Noel Doheny Chief Executive Officer of Epigenomics Inc.
Uwe Staub Chief Operating Officer
Albert Weber Senior Vice President Finance, Accounting and Controlling
Nicola Henneberg-Busse Vice President - Business Development
Annett Dietrich Manager Human Resources
Antje Zeise Manager Investor Relations
Ann Clare Kessler Member of the Supervisory Board
Guenther Reiter Member of the Supervisory Board
Age: 59